Literature DB >> 6602294

Cytotoxic T-cell immunity to influenza.

A J McMichael, F M Gotch, G R Noble, P A Beare.   

Abstract

In a study designed to determine whether cytotoxic T lymphocytes contribute to immunity against influenza virus infection, we inoculated 63 volunteers intranasally with live unattenuated influenza A/Munich/1/79 virus. Over the next seven days clinical observations were made, and the amount of virus shed was measured. The protective effects of preinfection serum antibody and of cytotoxic T-cell immunity against influenza A virus were assessed for each participant. All subjects with demonstrable T-cell responses cleared virus effectively. This response was observed in volunteers in all age groups, including those born after 1956, who did not have specific antibody and hence had probably not been exposed to this subtype of influenza A virus before. Cytotoxic T cells show cross-reactivity in their recognition of the different subtypes of influenza A virus, in contrast to the antibody response that is specific for each virus subtype. We conclude that cytotoxic T cells play a part in recovery from influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602294     DOI: 10.1056/NEJM198307073090103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  378 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

3.  Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.

Authors:  A A Haller; T Miller; M Mitiku; K Coelingh
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

Review 5.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 6.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

7.  CD8 T lymphocyte subset markers and HIV infection.

Authors:  A G Bird; K C Watret
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

8.  CD4+ T cells limit the damage in influenza.

Authors:  Anne Kelso
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

9.  Clinical and immunologic predictors of influenza illness among vaccinated older adults.

Authors:  Zainab Shahid; Alison Kleppinger; Beth Gentleman; Ann R Falsey; Janet E McElhaney
Journal:  Vaccine       Date:  2010-07-31       Impact factor: 3.641

10.  The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus.

Authors:  A R Thomsen; O Marker
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.